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Objectives: Prior studies demonstrated improved clinical outcomes for
surgeonswith a high volume experience with certain open vascular operations.
It is not known whether a high volume experience with carotid artery stenting
(CAS) improves clinical outcomes.Moreover, it is not knownwhether experi-
ence with other endovascular procedures, including percutaneous coronary
interventions (PCI), is an adequate substitute for experience with CAS. Our
objective was to assess the impact of increasing clinician volume of CAS, aortic
endografting (EVAR/TEVAR), and PCI on the outcomes for CAS.
Methods: The Nationwide Inpatient Sample was analyzed to identify
patients undergoing CAS for the years 2005-2009. Clinicians were stratiﬁed
into tertiles of low-, medium-, and high-volume groups based on annual
volume of CAS, EVAR/TEVAR, and PCI. Multiple logistic regression anal-
yses were used to examine the relationship between clinician volume and
a composite outcome of in-hospital stroke and death rate after CAS.
Results: Between 2005 and 2009, 83,072 elective CAS procedures
were performed nationwide with crude in-hospital stroke and death rates of
1.94% and 1.12%, respectively. The median number of CAS procedures per-
formed annually was seven per clinician (interquartile range, 2-17). Stroke
and death rates for CAS decreased with increasing volume of CAS performed
by a clinician (Table). Similar patterns were noted between clinicians’ volume
of EVAR/TEVAR and PCI and outcomes for CAS (Table). After adjusting
for patient and hospital characteristics, however, clinician volume was not
a signiﬁcant predictor of outcomes for CAS, while symptomatic status was the
dominant predictor of stroke and death after CAS (OR, 20.4; 95% CI, 15.3-
27.3; P < .0001). For asymptomatic patients, clinician volume of CAS
remained an independent predictor of stroke and death after CAS (OR, 0.79;
95% CI, 0.64-0.96, per 10 CAS cases; P ¼ .02), whereas clinician volume of
EVAR/TEVAR and PCI were not signiﬁcant predictors of outcome for CAS.
Conclusions: When treating asymptomatic carotid stenosis, the
stroke and death rate for CAS is 21% lower for every 10 CAS procedures
performed by a clinician. Clinicians with wire and catheter skills should be
advised that there is no substitute for experience with CAS to optimize
outcomes of CAS performed in asymptomatic patients.Table. Stroke and death rate for CAS stratiﬁed by tertiles of clinician
volume
Tertiles of CAS volume Stroke/death rate (%)
Tertile 1 (0-3 cases/y) 4.95%
Tertile 2 (3-13 cases/y) 2.11%
Tertile 3 (>13 cases/y) 1.79% (P < .0001)a
Tertiles of EVAR/TEVAR volume Stroke/death rate (%)
Tertile 1 (0-4 cases/y) 3.28%
Tertile 2 (4-14.5 cases/y) 2.17%
Tertile 3 (>14.5 cases/y) 1.91% (P ¼ .037)a
Tertiles of CAS volume Stroke/death rate (%)
Tertile 1 (0-5.3 cases/y) 3.21%
Tertile 2 (5.3-375.7 cases/y) 2.92%
Tertile 3 (>35.7 cases/y) 2.19% (P ¼ .02)a
aCochran-Armitage Trend Test.Long-Term Clinical Outcomes and Cardiovascular Events Following
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Objectives: Long-term atherosclerotic adverse events are anticipated
in patients undergoing carotid endarterectomy (CEA); however, their inci-
dence and risk predictors remain unknown.
Methods: A consecutive cohort of CEAs between January 1, 2000 and
December 31, 2007was analyzed. End points were any stroke, coronary event
(myocardial infarction, coronarybypass, or stenting), vascular interventions for
critical limb ischemia, aortic aneurysm or carotid disease, and death. Survival
analysis and Cox regression models were used to identify clinical predictors.Results: 1137 CEAs (bilateral 89, mean age 71.2 6 9.2 years; 56.5%
male; 36.3% symptomatic, 3.9% combined coronary artery bypass graft)
were performed during the study period with a mean clinical follow-up of
60 months (0-155 months). Thirty-day stroke and death rates were 2.0%
and 1.0%, respectively, stroke/death 2.7%). Freedom from a speciﬁc end
point at 5 and 10 years was stroke 92.8% and 83.9%; coronary events 81.6%
and 68.5%; and major vascular interventions 79.4% and 71.5%, respectively.
Survival at 5 and 10 years was 74.2% and 49.9%. Statins conferred a signiﬁcant
protective effect for stroke (HR, 0.52; P ¼ .012) and death (HR, 0.66; P <
.0001). Pre-existing vascular disease predicted future vascular interventions
(aortic aneurysm [HR, 1.89; P ¼ .001]; peripheral arterial disease [HR,
1.96; P < .0001]; contralateral internal carotid artery stenosis >50% [HR,
4.42; P < .0001]). Renal insufﬁciency predicted worse outcomes for all end
points (HR, 2.11; P¼ .04 for stroke; HR, 1.71; P¼ .002 for coronary events;
HR, 2.3; P < .0001 for death) except for major vascular interventions.
Conclusions: Patients undergoing CEA beneﬁt from low stroke rates
but still sustain major coronary events and vascular interventions, indicating
a need for more intensive medical treatment and rigorous follow-up.
Concurrent Carotid Endarterectomy and Coronary Artery Bypass
Grafting / Valve Replacement in Asymptomatic Patients with Severe
Carotid Stenosis: A Five Year Single Center Experience
Michael D. Lieb, Paul B. Haser, Saum A. Rahimi, Alan M. Graham. UNJ-
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Objectives: The optimal management of patients who require coro-
nary artery bypass grafting (CABG) or valve replacement that are found
to have severe carotid stenosis (80%-99%) remains controversial. There are
regional and institutional differences that determine whether these proce-
dures will be staged or performed concurrently because of concerns over
increased neurologic events, morbidity and/or mortality.
Methods: The charts of all patients undergoing combined carotid
endarterectomy (CEA)/CABG or CEA/valve replacement from July 2007
to December 2012 at a single university hospital setting were reviewed.
Demographic, stroke, death, operative times, and length of stay data were
collected for all patients. Patients who required simultaneous CABG and
valve replacement were not offered CEA. The 30-day stroke and mortality
rates were calculated. For purposes of comparison, we also reviewed the
patients with severe carotid stenosis undergoing CEA alone and patients
undergoing CABG or valve replacement alone during the same time period.
Results: 117 patients (73 male, 44 female) with severe carotid
stenosis undergoing combined procedures were identiﬁed (106 CEA/
CABG, 11 CEA/valve replacement). The stroke rate was 1.7% at 30
days, and the mortality rate was 2.6%, with only one death associated
with a late stroke, (postoperative day 59), for a combined stroke/death
rate of 4.3%. There were no deaths in the CEA/ valve replacement group.
The stroke and death rate for the 582 CEA patients during the same time
period was 0.5% with only two deaths during the 30-day time period. For
patients undergoing CABG or valve replacement alone, the combined
stroke/death rate was 3.5% in 2500 patients. The average operative time
for all patients in the series was 6.3 hours, and of patients who suffered
a postoperative stroke, the average operative time was 1.4 hours longer
for the three mortalities. The majority of patients were discharged on post-
operative day four vs 36 days for the two patients who suffered a stroke.
Conclusions: In patients with severe carotid stenosis and signiﬁcant
cardiac disease, combined surgery offers acceptable 30-day mortality and
stroke rates and provides the beneﬁt of only one anesthesia. Postoperative
stroke increased length of stay. Mortality was associated with signiﬁcantly
increased operative times, however, operative times did not impact the
rare occurrence of stroke in the series.
Repair of Large Internal Carotid Artery Aneurysm in a Patient with
Neuroﬁbromatosis Type 1
Saadat Shariff, Ashish Raju, Richard Smith, Michael Shih, Larry A. Scher,
Evan C. Lipsitz. Monteﬁore Medical Center, Bronx, NY
Objectives: Neuroﬁbromatosis type 1 is an autosomal dominant neu-
rocutaneous disorder characterized by café au lait macules, neuroﬁbromas
and Lisch nodules and is rarely associated with cerebrovascular aneurysms.
We describe a young male who presented with a 7-cm internal carotid artery
(ICA) aneurysm and its repair.
Methods: The patient is a 24-year-old African American male with
a history of neuroﬁbromatosis type 1 and scoliosis repair who presented
with a progressively enlarging right sided neck mass. There were no neuro-
logic deﬁcits, nor signs and symptoms of compression. Physical exam
showed a large pulsatile right neck mass. A computed tomography scan
and cervical angiogram demonstrated a 7.4-cm fusiform aneurysm of the
right ICA (Fig). The saphenous veins were occluded bilaterally. Operative
